When Does a Congenital Nevus Need Removal? How Dermatologists Weigh Monitoring Against Surgery

The mark was the first thing the midwife mentioned, even before the weight. A brown oval across a newborn’s left shoulder blade, a little larger than a bottle cap, with a soft scatter of fine hair. By the six-week check, the parents had a folder of printouts, two very different opinions from relatives, and one question they could not stop turning over: when to remove a congenital nevus, and whether removing it is even the right goal.

Dermatologists hear a version of that question most weeks. Sometimes it comes from a parent of an infant with a mark the size of a palm, sometimes from a teenager who has grown tired of a hairy patch on a forearm, sometimes from an adult who has carried a birthmark for forty years and just read a frightening headline.

The honest answer is that the evidence supports neither reflexive surgery nor benign neglect. It supports a weighing exercise, and the weights are more knowable than most people expect.

What a congenital nevus actually is, and why removal is even a question

A congenital melanocytic nevus, often shortened to CMN, is a mole present at birth or appearing within the first months of life. Melanocytes are the cells that make skin pigment; in a CMN, a cluster of them carried a genetic change while the skin was forming in the womb, so they multiplied into a patch that was already in place before the baby arrived. In most large nevi that change sits in a gene called NRAS, which normally helps regulate how cells divide, according to MedlinePlus Genetics.

That developmental origin matters more than it sounds. An ordinary mole acquired in childhood sits mostly in the upper skin. A congenital nevus tends to run deep: pigment cells track down along hair follicles, wrap around sweat glands and blood vessels, and in larger lesions extend into the fat beneath the skin. This is why a CMN is often thicker, darker and hairier than a typical mole, and it is also why any treatment that only skims the surface leaves most of the nevus behind.

Removal becomes a question for three separate reasons, and it helps to keep them apart from the start. The first is cancer: some of these cells can, over a lifetime, give rise to melanoma. The second is examination: a very dark, bumpy or hairy lesion can be genuinely hard to check for change. The third is life: how a visible mark affects a child’s confidence, a teenager’s social world, or an adult’s sense of self is a legitimate medical consideration, not a vanity one.

None of those three automatically wins. The rest of this article is about how clinicians weigh them, and where the evidence is firm versus where it is still thin.

How rare is a congenital nevus? Size categories that shape every decision

Small congenital nevi are common. MedlinePlus Genetics notes that congenital melanocytic nevi of some size occur in roughly 1 in 100 newborns, so most pediatricians see them regularly. The giant form is a different matter: it affects about 1 in 20,000 newborns worldwide, which means a busy children’s hospital may see only a handful of new cases a year.

Because a nevus grows in proportion to the body part it sits on, clinicians classify it by its projected adult size rather than what the tape measure shows on the day. A mark on an infant’s trunk will be considerably larger by adulthood; one on the scalp grows less because the head does most of its growing early.

Category	Projected adult diameter	Typical management emphasis
Small	Under 1.5 cm	Observation; excision mainly for appearance or change
Medium	1.5 to 19.9 cm	Observation or planned excision, case by case
Large	20 cm or more	Specialist team; possible brain imaging; staged surgery discussed
Giant	40 cm or more, or many satellites	Multidisciplinary care; risk to brain and skin weighed together

The thresholds come from the classification summarized by MedlinePlus Genetics and used in most dermatology references. They are not magic numbers. A 19 cm nevus is not meaningfully safer than a 20 cm one. What the categories capture is a gradient: the larger the lesion, and the more satellite nevi (smaller separate congenital moles scattered elsewhere on the body), the more the calculus tilts toward closer surveillance and toward involving a surgeon early. For the small end of the table, the calculus tilts the other way, and most of the anxiety parents carry is out of proportion to the risk their child’s mark actually poses.

Can congenital moles turn into melanoma? What the evidence really shows

Melanoma is a cancer that starts in pigment cells, and yes, it can arise in a congenital nevus. The useful question is how often, and here size dominates everything else.

For small and medium nevi, the lifetime risk is low and only modestly above the background risk any person carries. When melanoma does develop in these lesions, reviews summarized by MedlinePlus and Mayo Clinic describe a pattern that is reassuring in a practical sense: it usually appears after puberty, and it tends to arise in the upper, visible part of the nevus. A change that can be seen can be caught, which is precisely why monitoring rather than surgery is the default for small lesions.

For giant nevi, the picture is different. MedlinePlus Genetics cites estimates that roughly 5 to 10 percent of people with a giant congenital melanocytic nevus develop melanoma over their lifetime, while acknowledging that estimates vary and newer studies with careful follow-up have tended to report lower figures. Two features make this group harder to protect. A meaningful share of these melanomas appear in early childhood rather than adulthood, and they often start deep in the lesion, or even outside the skin altogether in the coverings of the brain and spinal cord, where no skin examination and no skin surgery can reach.

This last point deserves plain language because it is the single most misunderstood fact in the field. Removing a giant nevus reduces the amount of nevus tissue but does not bring the risk to zero, because some of the cells that matter were never in the removed skin. Surgeons who work with these families say so openly. It is not a reason to reject surgery; it is a reason to choose it for the right reasons, and to keep surveillance going afterward regardless of what was removed.

When to remove congenital nevus: the four things dermatologists weigh

No major guideline says every congenital nevus should come out, and none says every one should stay. What the literature summarized by NHS, Mayo Clinic and MedlinePlus converges on is a set of four considerations, weighed against the cost of surgery in scarring, anesthesia and recovery.

The first is malignant potential. This is largely a function of size and satellite count, as described above, and it is the reason large lesions are discussed with a surgeon early even when nothing looks wrong.

The second is monitorability, an ungainly word for a simple idea. A flat, evenly colored nevus can be photographed, measured and examined with a dermatoscope (a handheld magnifier with polarized light) every year for decades. A thick, black, nodular or densely hairy lesion often cannot be examined with confidence, and a melanoma arising in its depths could go unnoticed. When a lesion cannot be watched, removal starts to look like the more conservative choice, not the more aggressive one.

The third is symptoms. Large nevi may lack normal sweat glands, may itch persistently, may be fragile and ulcerate with minor friction, and may lack the fat padding of normal skin. These are quality-of-life problems that surgery can sometimes address.

The fourth is psychosocial impact. A conspicuous facial nevus, or one a child is teased about, carries real consequences for development and mental health. Dermatologists treat this as a medical indication, and so should families, without embarrassment.

Set against those four is the ledger of harm: every excision leaves a scar at least as long as the lesion, often longer; children need general anesthesia; staged procedures take months; and grafts and flaps carry their own complications. When to remove a congenital nevus is therefore never a single-variable decision, and a clinician who presents it as one is leaving something out.

Who is usually offered surgery, and who is usually asked to wait

Patterns emerge when you watch how specialist teams actually decide.

Surgery is usually offered when a nevus has changed in a way that worries the examining clinician, when a lesion is too thick or dark to monitor reliably, when a medium or large nevus sits somewhere an excision can close with an acceptable scar, when symptoms such as recurrent ulceration are affecting daily life, or when appearance is causing distress that the child or family articulates clearly. In those situations the benefit column has something concrete in it.

Waiting is usually recommended for small, flat, uniformly colored nevi in infants and young children. The reasoning is layered. The melanoma risk in this group is low and, when it occurs, tends to appear after puberty and in the visible portion of the lesion, so watching loses little. Removing a small mole in a squirming toddler generally requires general anesthesia, whereas the same procedure in a cooperative twelve-year-old can often be done with local anesthetic. Delay also lets the child have a voice in a decision about their own body.

Timing for large nevi is genuinely contested. Some surgeons favor operating in infancy because infant skin is more elastic and tissue expansion is easier, and because they hope to remove tissue before any early malignant change. Others point out that the cells most likely to cause childhood melanoma are often deep or outside the skin, that infant anesthesia is not without concern, and that a series of major operations in the first years of life has costs of its own. Mainstream references, including MedlinePlus Genetics, present both views rather than declaring a winner, and that is an accurate reflection of the evidence.

A child with extensive nevus involvement of the brain may be steered away from ambitious skin surgery altogether, because the skin is no longer where the greatest risk lies.

Neurocutaneous melanosis: why the brain sometimes matters more than the skin

Neurocutaneous melanosis is the presence of the same pigment-cell overgrowth in the coverings of the brain and spinal cord. MedlinePlus Genetics describes it as a recognized complication of large and giant congenital nevi, and it changes the entire conversation about removal.

Not every child with a large nevus has it. The risk rises with nevi that lie over the spine or the back of the head, with a large number of satellite nevi, and with multiple medium-sized congenital nevi rather than a single lesion. For children with those features, specialist teams commonly arrange magnetic resonance imaging of the brain and spine early in life, when the immature brain still allows pigment deposits to be seen clearly.

Most children whose scans show pigment in the meninges never develop symptoms. Some do, and the concerns include seizures, headaches from raised pressure inside the skull, vomiting, developmental delay and, rarely, melanoma arising inside the nervous system. These are the outcomes that shape the long-term prognosis for the highest-risk children, and no skin operation influences them.

This is the reason experienced teams insist on imaging results before mapping out a surgical plan for a giant nevus. If the scan is clear, the family and surgeon can talk about the skin on its own terms. If it shows extensive or symptomatic involvement, the burden of many staged operations may no longer be justified, and the team’s energy shifts toward neurology, seizure management and quality of life.

Parents often find this section the hardest to read, so it is worth restating the proportions. Neurocutaneous melanosis is a concern for a minority of children, those with large lesions in particular locations, and symptomatic disease is rarer still. For the 1-in-100 family with a small nevus, it does not enter the picture at all.

What congenital melanocytic nevus removal actually involves

The word removal covers several very different operations, and understanding them removes much of the fear.

Simple excision is what most people picture: the surgeon cuts around and beneath the nevus, taking it down to the fat, then closes the wound in layers. Because skin does not stretch infinitely, the incision is drawn as an ellipse roughly three times as long as the lesion is wide, so the resulting scar is a line longer than the mole it replaced. This is the standard approach for small and many medium nevi, and Mayo Clinic notes it is the usual method when a mole is removed for concern about cancer, because it provides a complete specimen for the laboratory.

Serial excision spreads the job over several sessions, typically months apart. A central strip is removed and closed; the surrounding skin loosens over time; another strip is taken. It trades a longer timeline for a shorter final scar and avoids grafts.

Tissue expansion places a silicone balloon under healthy skin next to the nevus. Over a period of weeks the balloon is gradually filled with saline through a small port, stretching the normal skin much as pregnancy stretches the abdomen. At a second operation the nevus is removed and the expanded skin is advanced to cover the defect. The result usually matches surrounding color and texture better than a graft, at the price of a visible bulge during the expansion phase.

Skin grafts and flaps borrow skin from elsewhere. Grafts often heal with a patchy, shiny appearance; flaps bring their own blood supply and tend to look more natural but leave a second scar at the donor site.

Every specimen goes to pathology. In children, all but the smallest excisions are performed under general anesthesia, which is why the anesthetic assessment is part of the decision, not an afterthought.

Dermabrasion, curettage and laser: what partial treatments can and cannot do

Because excision of a large nevus is so demanding, surgeons have long looked for gentler ways to lighten these lesions. Three deserve a plain description.

Dermabrasion sands away the upper layers of skin with a rotating instrument. Curettage scrapes the nevus off with a spoon-shaped tool; in the first weeks of life there is a natural plane between the superficial nevus and the deeper skin that makes this easier, which is why it is sometimes offered to newborns. Laser treatment uses light absorbed by pigment to destroy melanocytes near the surface.

All three share a strength and a weakness. The strength is that they can substantially lighten a nevus with less scarring and no grafts, which for a facial lesion can matter a great deal. The weakness follows from the biology described earlier: congenital nevus cells run deep, and these techniques do not reach them. Repigmentation over months or years is common, hair growth persists, and the treated surface may develop an unusual texture.

On the question that matters most to families, whether partial treatment lowers melanoma risk, the honest answer is that the evidence does not show that it does. The studies are small case series without comparison groups, and the deep and extracutaneous cells most implicated in childhood melanoma are exactly the ones left behind. Some dermatologists also raise a practical concern: a lesion that has been lightened and scarred can be harder to examine, and a melanoma developing beneath treated skin may be less visible than it would have been in the untouched nevus.

None of this makes partial treatment wrong. It makes it a cosmetic and symptomatic option, to be chosen with clear eyes about what it is for, and paired with the same lifelong surveillance the untreated nevus would have needed.

The days and weeks after congenital nevus surgery

Recovery depends on which operation was done, but the shape of it is predictable enough to plan around.

After a simple excision, the wound is usually covered with a dressing for a few days and kept dry at first. Stitches on the face are often removed within about a week, those on the trunk or limbs closer to two, though many surgeons now use dissolving sutures beneath the skin and skin glue on top so there is nothing to take out. Patient guidance from Mayo Clinic and MedlinePlus describes mild soreness for a few days and advises avoiding activities that stretch the wound, which for a child usually means no gymnastics, swimming or contact sports until the surgeon clears them.

The scar itself is the long game. It typically looks its worst somewhere in the first few months, red and raised, before flattening and fading over roughly a year or more. Silicone sheets or gels and firm sun protection are commonly suggested during this period; how much they change the final result is less certain than the marketing around them implies, and the surgical team is the right source of advice on whether to use them.

Tissue expansion has its own rhythm. After the balloon is placed, families return regularly for saline top-ups over weeks to a few months, watching the bulge grow. Discomfort is usually greatest for a day or so after each fill. The second operation, when the nevus is removed and the stretched skin moved across, is the larger one.

Serial excision spreads the whole experience across several smaller recoveries, each following the simple-excision pattern.

Whatever the route, the follow-up appointment matters as much as the operation. The pathology report is reviewed, the scar is checked, and the surveillance plan for any remaining nevus or for the skin as a whole is set out.

What good monitoring of a congenital nevus looks like

Monitoring is not the absence of a plan. Done well, it is a plan with a schedule, a baseline and a clear trigger for action.

The baseline is a set of good photographs with a ruler or coin in frame, taken in consistent light, plus written measurements. Many dermatologists add dermoscopy images, which record the pattern of pigment under magnification so that a subtle shift years later has something to be compared against. Parents are encouraged to take their own photos at home once or twice a year; the value is not in expert interpretation but in having a record when a question arises.

The interval is set by risk. For a small, flat nevus, an annual skin check that includes the nevus is usually sufficient, and Mayo Clinic advises the same yearly examination for anyone with a higher-than-average number of moles. Large nevi are generally seen more often, especially through childhood, and children with suspected neurocutaneous melanosis have a neurology plan alongside the skin plan.

Between visits, the aim is familiarity rather than vigilance. Parents who know what the mark normally looks like will notice a new firm lump, a patch of very different color, or an area that keeps bleeding without injury. Those are the changes that prompt a call; the slow proportional growth of a nevus keeping pace with a growing child is not.

Sun protection is the one thing families can actively do. Ultraviolet exposure is the main preventable driver of melanoma in ordinary skin, and while the evidence that it changes the behavior of a congenital nevus specifically is limited, CDC sun-safety advice on shade, clothing, hats and broad-spectrum sunscreen applies to the whole child, nevus included. Tanning beds are best avoided for anyone, and particularly for a teenager who already carries an elevated lifetime risk.

Does CMN go away? What changes are normal over the years

A congenital nevus does not disappear on its own. Families sometimes hear otherwise because these lesions do change, and some of the changes can look like fading.

In the first year, many nevi darken, and coarse hairs may appear where the skin was smooth at birth. Over childhood, a proportion of large nevi lighten noticeably, occasionally to a pale tan, though the texture and hair typically remain and the pigment cells are still there underneath. The NHS birthmarks guidance describes this evolution and notes that congenital moles, unlike some vascular birthmarks, are permanent.

Growth is expected and often frightening to parents until it is explained. A nevus enlarges in proportion to the body part it occupies, so a mark that covers a third of an infant’s thigh will still cover a third of the adult thigh. What clinicians watch for is growth out of proportion: a nodule rising from the surface, or one region expanding while the rest does not.

Bumps within a large nevus deserve a specific mention. Proliferative nodules are benign lumps that can appear in infancy and early childhood, sometimes quickly. They can be alarming, and because they can mimic melanoma under the microscope, they are usually examined by a specialist and often removed for pathology. Most turn out to be harmless, but this is not a judgment for families to make at home.

Puberty brings another round of change, with hormone-driven darkening and sometimes new hair growth. Adults may notice the nevus becoming softer and more wrinkled with age. Across all these decades the underlying answer to the search query stays the same: CMN does not go away, but it does not need to be feared every time it looks a little different, provided someone qualified is keeping an eye on it.

What people often get wrong about congenital nevus removal

Certain misconceptions come up so reliably that correcting them is half of a good consultation.

The first is that every congenital mole should be removed to be safe. For small lesions, surgery trades a low, monitorable risk for a certain scar and, in young children, a general anesthetic. Mainstream references including Mayo Clinic and the NHS describe observation as the standard approach for these.

The second is the mirror image: that removing a large nevus eliminates the melanoma risk. It does not, because cells may lie deeper than the excision or outside the skin entirely. Surveillance continues after surgery.

The third is that laser or dermabrasion is a safer, gentler removal. These treatments lighten the surface and leave the deeper nevus in place. They are cosmetic tools, not risk-reduction tools, and no study has shown that they prevent melanoma.

The fourth is that hair growing from a mole is a sign of cancer. The opposite is closer to the truth: hair follicles are a normal feature of congenital nevi, and a melanoma arising within a lesion tends to destroy follicles rather than grow them. Johns Hopkins patient information on moles makes the same point about ordinary hairy moles.

The fifth is that something the parent did during pregnancy caused the nevus. The genetic change occurs in a single cell early in development, is not inherited from either parent, and is not linked to diet, stress or exposures during pregnancy, as MedlinePlus Genetics explains.

The sixth is that a biopsy or partial removal will spread cancer. This fear is old and persistent, and the evidence does not support it. Sampling a suspicious area is how melanoma is diagnosed early, and it is far safer than waiting because of a myth.

Questions to ask your care team

A good consultation about a congenital nevus is a conversation, and families get more from it when they arrive with specific questions. The list below is not exhaustive, and the answers will differ from child to child, which is exactly the point: the plan should be built around this nevus, this body and this family.

• What is the projected adult size of this nevus, and which category does that put it in?
• Given its size and location, how would you describe its melanoma risk in plain terms, and how confident is the evidence behind that estimate?
• Does this nevus have features that make it hard to monitor, and would removal make surveillance easier or harder?
• Are there satellite nevi, and does their number or the nevus location mean brain and spine imaging should be considered?
• If you are recommending surgery, which technique, how many stages, and what would the scar realistically look like?
• If you are recommending observation, how often should we return, what will you record at each visit, and what changes should make us call sooner?
• What happens to the tissue after removal, and when will we hear about the pathology result?
• How does age affect this decision: what changes if we wait a year, or until adolescence?
• Who else should be involved, such as a plastic surgeon, a pediatric neurologist or a psychologist?
• Is there a patient support organization or registry you would suggest we contact?

It is reasonable to ask for a second opinion on any surgical plan for a large nevus, and clinicians who work in this field expect the request. It is also reasonable to say that you are not ready to decide. Except when a lesion is changing in a concerning way, the decision about when to remove a congenital nevus is rarely urgent, and a plan made thoughtfully over a few months is a better plan.

When to call your doctor

Most changes in a congenital nevus are benign, but a short list of signs should prompt a prompt appointment rather than a wait-and-see approach. These are prompts to seek assessment, not a tool for diagnosing anything at home.

Contact your dermatologist or pediatrician soon if you notice a new firm lump or nodule rising from within the nevus, a region that is growing faster than the rest or out of step with the child’s growth, an area of markedly different color developing within the lesion, bleeding, oozing, crusting or an open sore that was not caused by a knock and does not heal within a couple of weeks, persistent pain or itching localized to one part of the nevus, or a change in the border where one edge becomes irregular or blurred. Mayo Clinic and MedlinePlus describe the same features as the ones that warrant evaluation in any mole.

For a child with a large nevus, also seek advice for symptoms that could point to the nervous system: seizures, unexplained repeated vomiting, persistent headaches, unusual drowsiness or irritability, a bulging soft spot in an infant, or loss of skills the child had already gained.

After surgery, call the surgical team for fever, spreading redness or warmth around the wound, pus or foul-smelling discharge, a wound that opens, or bleeding that does not stop with gentle pressure.

Seek emergency care immediately for a seizure lasting more than a few minutes, a child who cannot be roused, or heavy bleeding that does not stop. In all other situations, the right first call is to the team already looking after the nevus, because they hold the photographs and measurements that turn a worrying observation into a clear comparison, and they are the ones who will decide what happens next.

Frequently asked questions

How rare is a congenital nevus?

Small congenital nevi are not rare at all: MedlinePlus Genetics notes that congenital melanocytic nevi of some size occur in about 1 in 100 newborns. Giant nevi are genuinely uncommon, affecting roughly 1 in 20,000 babies worldwide. That gap explains why most families with a congenital mole are reassured after one examination, while a small number are referred to specialist teams for lifelong follow-up.

Can congenital moles turn into melanoma?

Yes, but the likelihood depends heavily on size. Small and medium nevi carry a low lifetime risk only slightly above background, and melanoma in them usually appears after puberty in the visible part of the lesion. For giant nevi, MedlinePlus Genetics cites estimates of roughly 5 to 10 percent, with newer follow-up studies tending to report lower figures, and a share of those cases occur in childhood or outside the skin.

Does CMN go away on its own?

No. A congenital melanocytic nevus is permanent, although it changes over time. Many darken and grow hair in infancy, some large lesions lighten noticeably through childhood, and all of them enlarge in proportion to the body part they sit on. Fading of color does not mean the pigment cells have gone; they remain in the deeper skin and still need the same routine monitoring.

How is a congenital nevus treated?

Most small congenital nevi are simply monitored with periodic examination and photographs. When treatment is chosen, options include simple excision, serial excision in stages, tissue expansion followed by removal, and skin grafts or flaps for large defects. Partial techniques such as dermabrasion, curettage and laser can lighten appearance but do not remove deep cells. The choice rests with the child’s dermatology and surgical team.

Does congenital melanocytic nevus removal eliminate the cancer risk?

Not entirely. Excision removes the nevus tissue in the skin, but congenital nevus cells can extend into fat and, with large lesions, into the coverings of the brain and spinal cord, where surgery on the skin has no effect. For that reason clinicians continue skin and, where relevant, neurological surveillance after removal. Surgery is chosen to reduce risk, ease monitoring or improve appearance, not to guarantee anything.

Is laser removal of a congenital nevus effective?

Laser can lighten the color of a congenital nevus, and for a facial lesion that may be valuable. It does not reach the deep pigment cells that characterize these lesions, so repigmentation is common and hair persists. No study has shown that laser treatment reduces melanoma risk, and some dermatologists worry that treated skin is harder to examine. It is best understood as a cosmetic option, discussed with a specialist.

Should a congenital nevus be removed in infancy or later?

For small, flat nevi, most clinicians advise waiting, because the risk is low and a cooperative older child can often have the procedure under local anesthetic. For large nevi the timing is debated: infant skin stretches more easily, but the cells most linked to childhood melanoma are often deep or outside the skin. Mainstream references present both views, and the decision belongs with the treating team.

Does hair growing from a congenital mole mean it is dangerous?

No. Hair follicles are a normal component of congenital nevi, which is why these moles are often hairier than acquired ones. A melanoma developing inside a lesion tends to destroy follicles rather than produce hair. The changes that do warrant assessment are a new firm lump, a patch of very different color, or a sore that bleeds or fails to heal without injury.

What is a satellite nevus and why do doctors count them?

A satellite nevus is a smaller congenital mole located away from the main lesion, often scattered across the trunk or limbs. Their number matters because a high count, together with a large main nevus over the spine or head, is associated with a greater chance of pigment cells in the coverings of the brain and spinal cord. Clinicians use the count when deciding whether early brain imaging is worthwhile.

Do adults with a congenital nevus still need it checked?

Yes. Melanoma arising in small and medium congenital nevi typically appears after puberty, so adulthood is precisely when a yearly skin check matters. Adults with large nevi carry a lifelong elevated risk and benefit from continued specialist follow-up. Any adult who notices a new lump, color change or non-healing area within a long-standing birthmark should arrange an examination rather than assume it is age-related.

References

• MedlinePlus Genetics: Giant congenital melanocytic nevus
• NHS: Birthmarks
• MedlinePlus: Moles
• CDC: Sun safety

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.